Catalyst Wire Dossier Catalyst Wire Dossier

Immune Checkpoint Inhibitor (ICI) - DDI Study

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immune Checkpoint Inhibitor (ICI) - DDI Study, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study [EARLY_Phase 1]

See pricing